Lyla Stanland
- Enfuego Therapeutics Inc. (no department on record)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
FY2025 NIH rank #17,964
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 16139667Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
NIH Funding · FY2025
Linked Award Amount
$919K
Full award amounts, FY2025
Award Records
1
Records listing this PI
Award-Linked Rank
#17,964
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2025 award records by amount
NIH award records listing Lyla Stanland as a PI. Multi-PI records show the full award amount for context.
- 5R44CA284932-03R44Contact PILigand-Directed KRAS G12V Mutant-Specific Therapeutics$919Kaward amount
Award organization
Organizations that administered FY2025 awards listing Lyla Stanland as a PI.
FY2025 award administered by Enfuego Therapeutics Inc. (NC).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardEnfuego Therapeutics Inc.
- 2024$500K Cumulative Funding
- 2025$1M Cumulative Funding
- 2026$2M Cumulative Funding
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Lyla Stanland.